| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.28▲ | 0.28▲ | 0.28▲ | 0.30▼ | 0.30▼ |
| MA10 | 0.28▲ | 0.29▲ | 0.29▼ | 0.31▼ | 0.37▼ |
| MA20 | 0.29▼ | 0.29▼ | 0.29▼ | 0.32▼ | 0.38▼ |
| MA50 | 0.29▼ | 0.31▼ | 0.31▼ | 0.39▼ | 0.54▼ |
| MA100 | 0.31▼ | 0.31▼ | 0.31▼ | 0.39▼ | 1.46▼ |
| MA200 | 0.31▼ | 0.32▼ | 0.36▼ | 0.51▼ | 7.05▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▲ | -0.001▼ | 0.002▲ | 0.007▲ |
| RSI | 41.113▼ | 37.162▼ | 34.702▼ | 35.598▼ | 36.041▼ |
| STOCH | 58.087 | 18.390▼ | 12.960▼ | 36.308 | 6.257▼ |
| WILL %R | -51.220 | -75.155▼ | -78.610▼ | -93.084▼ | -98.660▼ |
| CCI | 42.691 | -36.663 | -64.889 | -153.959▼ | -113.229▼ |
|
Friday, August 14, 2026 05:01 AM
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 ...
|
|
Sunday, June 07, 2026 05:00 PM
A clinical-stage immuno-oncology company has moved three drug candidates into human testing over time --- and most recently expanded into solid tumors --- while carrying a market value that remains ...
|
|
Tuesday, June 02, 2026 06:02 AM
SAN FRANCISCO, June 2, 2026 /CNW/ -- Most clinical-stage cancer companies with three drugs dosing patients in human trials carry valuations in the hundreds of millions, or more. GT Biopharma, Inc.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/08/26 | 0.29 | 0.2929 | 0.2814 | 0.285 | 540,656 |
| 14/08/26 | 0.295 | 0.3062 | 0.2871 | 0.296 | 628,224 |
| 13/08/26 | 0.3011 | 0.305 | 0.295 | 0.2974 | 502,996 |
| 12/08/26 | 0.32 | 0.3205 | 0.3012 | 0.3021 | 553,975 |
| 11/08/26 | 0.331 | 0.3346 | 0.31 | 0.3128 | 223,004 |
| 10/08/26 | 0.3201 | 0.3317 | 0.3105 | 0.3206 | 408,363 |
| 07/08/26 | 0.301 | 0.3275 | 0.301 | 0.3201 | 568,207 |
| 06/08/26 | 0.3175 | 0.3238 | 0.301 | 0.301 | 248,095 |
| 05/08/26 | 0.3233 | 0.3314 | 0.3133 | 0.3175 | 232,234 |
| 04/08/26 | 0.31 | 0.3348 | 0.3099 | 0.3261 | 423,540 |
|
|
||||
|
|
||||
|
|